| Name | Title | Contact Details |
|---|---|---|
Yancy Harlow |
VP, Information Technology | Profile |
But that doesn’t mean your network, storage, and security issues are exactly like anyone else’s. So our approach won’t be, either. We’ll structure our team and…
The Seminar Network is a platform that connects and empowers social entrepreneurs to tackle the major challenges of our time.
At ePlus, we engineer transformative technology solutions for the most visionary companies in the world.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Ramco Systems offers cloud, mobile, chatbot and Voice-ready ERP, HR, Global Payroll, Logistics, EAM and Aviation M&E MRO Software. We build Active ERP infused with AI and ML.